Tumor mutation burden and recurrent tumors in hereditary lung cancer
|
journal
|
April 2019 |
Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas: Mutational signature associated with MUTYH deficiency in cancers
|
journal
|
March 2017 |
Personalised Treatment in Gastric Cancer: Myth or Reality?
|
journal
|
May 2016 |
Precision oncology in the age of integrative genomics
|
journal
|
January 2018 |
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
|
journal
|
September 2016 |
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
|
journal
|
March 2017 |
BRCAness revisited
|
journal
|
January 2016 |
Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
|
journal
|
October 2017 |
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
|
journal
|
November 2017 |
Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
|
journal
|
April 2018 |
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
|
journal
|
November 2018 |
The genetic landscape of 5T models for multiple myeloma
|
journal
|
October 2018 |
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer
|
journal
|
March 2019 |
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
|
journal
|
April 2020 |
Targeting deficient DNA damage repair in gastric cancer
|
journal
|
August 2016 |
Computational approaches for discovery of mutational signatures in cancer
|
journal
|
July 2017 |
Understanding mutagenesis through delineation of mutational signatures in human cancer
|
journal
|
May 2016 |
Exploring background mutational processes to decipher cancer genetic heterogeneity
|
journal
|
May 2017 |
SigLASSO: a LASSO approach jointly optimizing sampling likelihood and cancer mutation signatures
|
posted_content
|
May 2018 |
Genomic aberration based molecular signatures efficiently characterize homologous recombination deficiency in prostate cancer
|
posted_content
|
June 2019 |
Mutational signatures associated with tobacco smoking in human cancer
|
journal
|
November 2016 |
Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas
|
journal
|
August 2017 |
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
|
journal
|
March 2019 |
Portrait of a cancer: mutational signature analyses for cancer diagnostics
|
journal
|
May 2019 |
Actionable gene-based classification toward precision medicine in gastric cancer
|
journal
|
October 2017 |
FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures
|
journal
|
December 2019 |
Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient colorectal cancer cell model
|
journal
|
January 2020 |
Mutational signatures associated with tobacco smoking in human cancer
|
posted_content
|
May 2016 |
Computational approaches for discovery of mutational signatures in cancer
|
posted_content
|
June 2017 |
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
|
text
|
January 2017 |
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
|
text
|
January 2016 |
Computational approaches for discovery of mutational signatures in cancer.
|
text
|
January 2019 |
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
|
text
|
January 2019 |
Base changes in tumour DNA have the power to reveal the causes and evolution of cancer
|
journal
|
June 2016 |
A proteogenomic approach for protein-level evidence of genomic variants in cancer cells
|
journal
|
October 2016 |
KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer
|
journal
|
January 2016 |
The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
|
journal
|
January 2018 |
The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils.
|
journalarticle
|
January 2018 |
Platelet distribution width correlates with prognosis of gastric cancer
|
journal
|
February 2017 |
Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer
|
journal
|
August 2017 |
The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
|
journal
|
November 2017 |
Somatic genome alterations in relation to age in lung squamous cell carcinoma
|
journal
|
August 2018 |
Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
|
journal
|
September 2016 |
The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents
|
journal
|
March 2019 |
Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma
|
journal
|
March 2019 |